Apart from the activating NRAS mutations (linked with high NRAS expression) and the inactivating NF1 mutations (linked with decreased NF1 expression), all the other mutations were randomly distributed across all melanoma tumors, irrespective of their gene expression (Figure 6). This evidence concerns the gene NRAS and melanoma.